CHEYENNE, Wyo., Jan. 26, 2017 /PRNewswire/ -- The directors and management of N1 Technologies Corp. (OTC PINK:NNSV) announced today that NanoSave Technologies has acquired all rights and titles to the Viritron VDX, Viritron VPN and Viritron Mini Lab patents, representing an overall increase IP valuation. "NanoSave Technologies is a Global leader in Nano Technology research and development and this latest asset acquisition is another development in our desire to create a stand alone Bio Technology division for our company," states CEO Steve Lovern. " N1 Technologies Corp. a Bio Technology research company will trade as NanoSave Technologies OTC: NNSV going forward. This unites all the Nano Technology patents and products under one roof allowing investors to own a part of all our innovations with one stock," Mr. Lovern went on to say. N1 Technologies Corp. the new Bio Tech division has set up its Executive offices in Atlanta Georgia in the fashionable Dunwoody area.
In Other News, NanoSave Technologies is preparing to post its Q4 2016 Financial statements which will reflect the company's acquisition of the Viritron Patents and 4th quarter revenues. The company continues to expand rapidly, corporate accountants have indicated that the forth quarter numbers were clearly positive and may have exceeded initial expectations. "We feel very strongly that our numbers will be a pleasant surprise as we combine the operating accounts of NanoSave and N1 into a consolidated financial statement, with both assets and revenues hitting all time highs. We are looking forward to opening new markets in the bio technology arenas and streamlining all aspects of our operations," says Company CEO Steve Lovern. The company envisages these new Bio Tech Patents and Technologies as an exceptional opportunity for our investors going forward. NanoSave Technologies designs, develops, manufactures and markets a wide range of nano-engineered oil products, lubricants and marine coatings to a global market.